18.207.132.226
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Industry News

Most ophthalmic drug approvals over last 20 years were reformulations

Similar to the rest of the industry, novel ophthalmic pharmaceutical development declined over the past 2 decades, with the majority of approvals coming in the form of reformulations of prior pharmaceuticals, according to a study published in Ophthalmic Epidemiology. However, new legislation has the potential to increase novel therapeutic development....

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-